A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/100, 167/103
A61K 9/06 (2006.01) A61K 37/02 (1990.01)
Patent
CA 1335566
A method for enhancing or restoring lacrimal function by the topical administration of a cyclosporin in a pharmaceutically acceptable excipient. Lacrimal function is enhanced or restored in patients suffering from abnormalities of the tear film including an absolute or partial deficiency in aqueous tear production, called keratoconjunctivitis sicca or KCS, regardless of etiology, including autoimmune dysfunction of the lacrimal glands. The treatment is also useful in the enhancement or restoration of normal tear production, and normal healing of the surface of the eye. The preferred composition for topical administration to the eye consists of cyclosporin dissolved in corn oil. The composition may further include antioxidants, lubricants, antibiotics, antifungals, antivirals, pilocarpine, vasoconstrictors, surfactants, wetting agents, anti-inflammatory agents (i.e. corticosteroids), preservatives, mucolytic agents (i.e. bromhexine, acetylcysteine), as well as other compounds. The most preferred composition is 2% cyclosporin, 1 mole % alpha tocopherol and 0.005% methyl paraben in corn oil.
597210
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
University Of Georgia Research Foundation Inc.
LandOfFree
Ocular cyclosporin composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ocular cyclosporin composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular cyclosporin composition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1196797